Williams Charles queen Camilla Britain France county Prince William city Omaha community Sun reports Party UPS Тикеры Williams Charles queen Camilla Britain France county Prince William city Omaha

King Charles had 'cancer treatment 24 hours before' his moving D-Day speech

Reading now: 986
www.dailyrecord.co.uk

King Charles has been revealed to have led the D-Day commemorations in Normandy, a mere 24 hours after undergoing cancer treatment in hospital.At the age of 75, Charles received medical care at a London hospital on Tuesday but was resolute in his commitment to be present with veterans the next day, aiming to "lead from the front."On Wednesday, he first made his way to Portsmouth where he gave an eight-minute speech.The emotional impact of the King's words was evident as Queen Camilla was seen with tears in her eyes.

The royal couple later spent time with some of the 21 invited D-Day heroes during the event. Following medical advice, Charles curtailed his scheduled appearance by 45 minutes, reports the Mirror.

His "carefully calibrated" participation then took him swiftly to Normandy, France, for the significant 80th-anniversary commemoration, as reported by the Sun.

There, King Charles delivered a stirring tribute to the D-Day heroes at the British Normandy Memorial, which bears the names of the 22,442 individuals who lost their lives on D-Day and the French civilians who perished during the war in Normandy.He called upon people to draw lessons from history and urged free nations to unite against despotism.

Read more on dailyrecord.co.uk
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

Susan Hopkins - COVID-19 variants identified in the UK – latest updates - gov.uk - Britain - city Oxford
gov.uk
66%
384
COVID-19 variants identified in the UK – latest updates
UKHSA) has published its containing updated analysis of the emergent variant BA.2.86.BA.2.86 continues to transmit within the UK, with sporadic cases identified in most regions.The briefing contains early laboratory data from a number of scientific organisations around the UK, including UKHSA’s own Vaccine Development and Evaluation Centre (VDEC), the University of Oxford, the Glasgow Centre of Virus Research and the Pirbright Institute.This early data indicates that BA.2.86 is no more likely to evade existing antibodies than XBB.1.5, another variant that has been circulating widely in the UK.While the available data remains limited, there is currently no evidence to suggest that BA.2.86 infection is more likely to make people seriously ill than currently-circulating variants, while vaccination is likely to provide continued protection.UKHSA will continue to monitor vaccine effectiveness in the population throughout the winter and will publish updated analysis in due course.Professor Susan Hopkins, Chief Medical Advisor, UKHSA said:While this is still very early data and more research is needed before we can be certain, it is encouraging to see an initial indication that BA.2.86 demonstrates similar levels of antibody escape compared to other variants circulating in the UK. The available data is too limited to draw conclusions about the severity of the illness it causes, but there is so far no evidence to suggest that it is more likely to make people seriously ill than other Omicron variants in circulation.The autumn vaccination programme started this month, and this new data shows once again how important it is that the most vulnerable among us are fully vaccinated in order to receive the greatest possible protection.
DMCA